Farallon Capital Management LLC Biogen Inc. Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $4.32 Million - $4.99 Million	-15,700 Reduced 2.53%	604,098 $172 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $6.95 Million - $7.92 Million	27,099 Added 4.57%	619,798 $172 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $72.5 Million - $88.1 Million	287,200 Added 94.01%	592,699 $164 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $5.26 Million - $7.25 Million	27,000 Added 9.69%	305,499 $81.6 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $15.1 Million - $18 Million	80,700 Added 40.8%	278,499 $56.8 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $9.71 Million - $12.2 Million	50,090 Added 33.91%	197,799 $41.7 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $5.18 Million - $6.66 Million	-23,150 Reduced 13.55%	147,709 $35.4 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $17.5 Million - $22.8 Million	61,859 Added 56.75%	170,859 $48.4 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $1.55 Million - $2.49 Million	6,000 Added 5.83%	109,000 $37.7 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $24.3 Million - $36.6 Million	103,000 New	103,000 $25.2 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $73.1 Million - $95.6 Million	-249,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $23.4 Million - $27.9 Million	-91,000 Reduced 26.76%	249,000 $72.3 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $52 Million - $73.6 Million	-200,000 Reduced 37.04%	340,000 $93.1 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $20 Million - $22.4 Million	65,000 Added 13.68%	540,000 $172 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $134 Million - $157 Million	475,000	475,000 $149 Million

Others Institutions Holding BIIB

# of Institutions

1,006

Shares Held

129M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account